<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>36(9)</volume><submitter>Nieto PA</submitter><funding>Seeding Inc. DBA Tiny Health</funding><pubmed_abstract>&lt;h4>Background&lt;/h4>Infants born via Cesarean section (C-section) often have a distinct gut microbiome and higher risks of atopic and immune-related conditions than vaginally delivered infants. We evaluated whether a microbiome-based program could shift gut microbiome composition and improve microbiome-associated health outcomes in C-section born infants.&lt;h4>Methods&lt;/h4>This open-label, randomized, controlled trial included full-term C-section-born infants aged 0-3 months, randomized to an intervention (n = 25) or control arm (n = 29). Over 6 months, the intervention arm received two microbiome reports, personalized recommendations based on their microbiome, educational materials, and coaching calls focused on microbiome health. Parents reported health conditions via surveys.&lt;h4>Primary out</pubmed_abstract><journal>Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology</journal><pagination>e70182</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12405607</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Improving immune-related health outcomes post-cesarean birth with a gut microbiome-based program: A randomized controlled trial.</pubmed_title><pmcid>PMC12405607</pmcid><pubmed_authors>Yuan Q</pubmed_authors><pubmed_authors>Song E</pubmed_authors><pubmed_authors>Tan DS</pubmed_authors><pubmed_authors>Hoy CS</pubmed_authors><pubmed_authors>Orlandi A</pubmed_authors><pubmed_authors>Nieto PA</pubmed_authors><pubmed_authors>Trachsel J</pubmed_authors><pubmed_authors>Nakama C</pubmed_authors><pubmed_authors>Mueller NT</pubmed_authors><pubmed_authors>Soderborg TK</pubmed_authors><pubmed_authors>Mars RA</pubmed_authors><pubmed_authors>Sukhum KV</pubmed_authors><pubmed_authors>Goad D</pubmed_authors></additional><is_claimable>false</is_claimable><name>Improving immune-related health outcomes post-cesarean birth with a gut microbiome-based program: A randomized controlled trial.</name><description>&lt;h4>Background&lt;/h4>Infants born via Cesarean section (C-section) often have a distinct gut microbiome and higher risks of atopic and immune-related conditions than vaginally delivered infants. We evaluated whether a microbiome-based program could shift gut microbiome composition and improve microbiome-associated health outcomes in C-section born infants.&lt;h4>Methods&lt;/h4>This open-label, randomized, controlled trial included full-term C-section-born infants aged 0-3 months, randomized to an intervention (n = 25) or control arm (n = 29). Over 6 months, the intervention arm received two microbiome reports, personalized recommendations based on their microbiome, educational materials, and coaching calls focused on microbiome health. Parents reported health conditions via surveys.&lt;h4>Primary out</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Sep</publication><modification>2026-05-29T22:02:25.791Z</modification><creation>2026-04-08T06:13:09.904Z</creation></dates><accession>S-EPMC12405607</accession><cross_references><pubmed>40898384</pubmed><doi>10.1111/pai.70182</doi></cross_references></HashMap>